Invest in a Healthier World:
Backing Innovation that Saves Lives
At HeartForce™, we are radically transforming the detection of coronary artery disease. We believe that early detection of cardiovascular disease saves lives and helps reduce healthcare costs. That’s why we’re shaping the future of cardiac diagnostics to make it possible. As an investor, you’re not just backing a product; you’re helping shift the paradigm in preventive medicine.
Our vision is bold but clear: we are building a future where the early detection of coronary artery disease is accessible, accurate, affordable, and patient-friendly.
Fast.
Low cost.
Secure data handling.
Supported by clinical validation, cutting-edge AI, and a strong commitment to regulatory excellence — including EUDAMED registration and the assignment of our Single Registration Number (SRN) — we are advancing scalable solutions for earlier detection of cardiovascular disease.
Our mission is to transform cardiovascular care by enabling accurate, accessible and patient-friendly heart screening, beginning with coronary artery disease (CAD), the world’s leading cause of death¹.
This section provides a detailed view of our business performance and future direction. Whether you’re a potential investor or long-standing partner, you’ll find the information needed to support informed and purposeful investment decisions.
Lab to Market
Follow our journey from technology development through clinical validation and international regulatory processes. Discover how our mission grows into a market-ready solution ready for adoption worldwide.
Investor Inquiries
If you would like to know more about our business plan, revenue model and investment thesis, future product pipeline of other strategic updates.